Literature DB >> 20153221

CD95-ligand on peripheral myeloid cells activates Syk kinase to trigger their recruitment to the inflammatory site.

Elisabeth Letellier1, Sachin Kumar, Ignacio Sancho-Martinez, Stefanie Krauth, Anne Funke-Kaiser, Sabrina Laudenklos, Katrin Konecki, Stefan Klussmann, Nina S Corsini, Susanne Kleber, Natalia Drost, Andreas Neumann, Matthieu Lévi-Strauss, Benedikt Brors, Norbert Gretz, Lutz Edler, Carmen Fischer, Oliver Hill, Meinolf Thiemann, Bahram Biglari, Saoussen Karray, Ana Martin-Villalba.   

Abstract

Injury to the central nervous system initiates an uncontrolled inflammatory response that results in both tissue repair and destruction. Here, we showed that, in rodents and humans, injury to the spinal cord triggered surface expression of CD95 ligand (CD95L, FasL) on peripheral blood myeloid cells. CD95L stimulation of CD95 on these cells activated phosphoinositide 3-kinase (PI3K) and metalloproteinase-9 (MMP-9) via recruitment and activation of Syk kinase, ultimately leading to increased migration. Exclusive CD95L deletion in myeloid cells greatly decreased the number of neutrophils and macrophages infiltrating the injured spinal cord or the inflamed peritoneum after thioglycollate injection. Importantly, deletion of myeloid CD95L, but not of CD95 on neural cells, led to functional recovery of spinal injured animals. Our results indicate that CD95L acts on peripheral myeloid cells to induce tissue damage. Thus, neutralization of CD95L should be considered as a means to create a controlled beneficial inflammatory response. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20153221     DOI: 10.1016/j.immuni.2010.01.011

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  54 in total

Review 1.  Harnessing programmed cell death as a therapeutic strategy in rheumatic diseases.

Authors:  Madhu Ramaswamy; Min Deng; Richard M Siegel
Journal:  Nat Rev Rheumatol       Date:  2011-02-01       Impact factor: 20.543

2.  Fas signal promotes the immunosuppressive function of regulatory dendritic cells via the ERK/β-catenin pathway.

Authors:  Cheng Qian; Li Qian; Yizhi Yu; Huazhang An; Zhenhong Guo; Yanmei Han; Yongjian Chen; Yi Bai; Qingqing Wang; Xuetao Cao
Journal:  J Biol Chem       Date:  2013-08-13       Impact factor: 5.157

3.  Activated cytotoxic lymphocytes promote tumor progression by increasing the ability of 3LL tumor cells to mediate MDSC chemoattraction via Fas signaling.

Authors:  Fei Yang; Yinxiang Wei; Zhijian Cai; Lei Yu; Lingling Jiang; Chengyan Zhang; Huanmiao Yan; Qingqing Wang; Xuetao Cao; Tingbo Liang; Jianli Wang
Journal:  Cell Mol Immunol       Date:  2014-04-28       Impact factor: 11.530

4.  Prevention of both neutrophil and monocyte recruitment promotes recovery after spinal cord injury.

Authors:  Sang Mi Lee; Steven Rosen; Philip Weinstein; Nico van Rooijen; Linda J Noble-Haeusslein
Journal:  J Neurotrauma       Date:  2011-08-08       Impact factor: 5.269

5.  Tight squeeze, slow burn: inflammation and the aetiology of cervical myelopathy.

Authors:  Michael S Beattie; Geoffrey T Manley
Journal:  Brain       Date:  2011-05       Impact factor: 13.501

Review 6.  Repertoire of microglial and macrophage responses after spinal cord injury.

Authors:  Samuel David; Antje Kroner
Journal:  Nat Rev Neurosci       Date:  2011-06-15       Impact factor: 34.870

7.  Neutrophil expression of Fas ligand and perforin directs effector CD8 T cell infiltration into antigen-challenged skin.

Authors:  Danielle D Kish; Anton V Gorbachev; Neetha Parameswaran; Neetu Gupta; Robert L Fairchild
Journal:  J Immunol       Date:  2012-07-18       Impact factor: 5.422

8.  Intravenous immune-modifying nanoparticles as a therapy for spinal cord injury in mice.

Authors:  Su Ji Jeong; John G Cooper; Igal Ifergan; Tammy L McGuire; Dan Xu; Zoe Hunter; Sripadh Sharma; Derrick McCarthy; Stephen D Miller; John A Kessler
Journal:  Neurobiol Dis       Date:  2017-08-18       Impact factor: 5.996

9.  Fas signaling in macrophages promotes chronicity in K/BxN serum-induced arthritis.

Authors:  Qi-Quan Huang; Robert Birkett; Renee E Koessler; Carla M Cuda; G Kenneth Haines; Jian-Ping Jin; Harris Perlman; Richard M Pope
Journal:  Arthritis Rheumatol       Date:  2014-01       Impact factor: 10.995

10.  Signaling lymphocyte activation molecule regulates development of colitis in mice.

Authors:  Boaz van Driel; Gongxian Liao; Xavier Romero; Michael S O'Keeffe; Guoxing Wang; William A Faubion; Scott B Berger; Erica M Magelky; Monika Manocha; Veronica Azcutia; Matthew Grisham; Francis W Luscinskas; Emiko Mizoguchi; Rene de Waal Malefyt; Hans-Christian Reinecker; Atul K Bhan; Ninghai Wang; Cox Terhorst
Journal:  Gastroenterology       Date:  2012-09-06       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.